117 related articles for article (PubMed ID: 38885922)
21. Regression of Coronary Fatty Plaque and Risk of Cardiac Events According to Blood Pressure Status: Data From a Randomized Trial of Eicosapentaenoic Acid and Docosahexaenoic Acid in Patients With Coronary Artery Disease.
Welty FK; Hariri E; Asbeutah AA; Daher R; Amangurbanova M; Chedid G; Elajami TK; Alfaddagh A; Malik A
J Am Heart Assoc; 2023 Sep; 12(18):e030071. PubMed ID: 37681568
[TBL] [Abstract][Full Text] [Related]
22. The effect of omega-3 fatty acids on coronary atherosclerosis quantified by coronary computed tomography angiography.
Feuchtner G; Langer C; Barbieri F; Beyer C; Dichtl W; Friedrich G; Schgoer W; Widmann G; Plank F
Clin Nutr; 2021 Mar; 40(3):1123-1129. PubMed ID: 32778459
[TBL] [Abstract][Full Text] [Related]
23. Supplementation with high-dose docosahexaenoic acid increases the Omega-3 Index more than high-dose eicosapentaenoic acid.
Allaire J; Harris WS; Vors C; Charest A; Marin J; Jackson KH; Tchernof A; Couture P; Lamarche B
Prostaglandins Leukot Essent Fatty Acids; 2017 May; 120():8-14. PubMed ID: 28515020
[TBL] [Abstract][Full Text] [Related]
24. Impact of coronary artery calcium progression and statin therapy on clinical outcome in subjects with and without diabetes mellitus.
Kiramijyan S; Ahmadi N; Isma'eel H; Flores F; Shaw LJ; Raggi P; Budoff MJ
Am J Cardiol; 2013 Feb; 111(3):356-61. PubMed ID: 23206921
[TBL] [Abstract][Full Text] [Related]
25. Effects of Fatty Acid Therapy in Addition to Strong Statin on Coronary Plaques in Acute Coronary Syndrome: An Optical Coherence Tomography Study.
Kita Y; Watanabe M; Kamon D; Ueda T; Soeda T; Okayama S; Ishigami K; Kawata H; Horii M; Inoue F; Doi N; Okura H; Uemura S; Saito Y
J Am Heart Assoc; 2020 Aug; 9(16):e015593. PubMed ID: 32805184
[TBL] [Abstract][Full Text] [Related]
26. Extent of subclinical atherosclerosis on coronary computed tomography and impact of statins in patients with diabetes without known coronary artery disease: Results from CONFIRM registry.
Shaikh K; Ahmed A; Gransar H; Lee J; Leipsic J; Nakanishi R; Alla V; Bax JJ; Chow BJW; Berman DS; Maffei E; Lin FY; Ahmad A; DeLago A; Pontone G; Feuchtner G; Marques H; Min JK; Hausleiter J; Hadamitzky M; Kaufmann PA; de Araújo Gonçalves P; Cury RC; Kim YJ; Chang HJ; Rubinshtein R; Villines TC; Lu Y; Shaw LJ; Acenbach S; Al Mallah MH; Andreini D; Cademartiri F; Callister TQ; Budoff MJ
J Diabetes Complications; 2022 Dec; 36(12):108309. PubMed ID: 36444796
[TBL] [Abstract][Full Text] [Related]
27. The role of coronary artery calcification testing in incident coronary artery disease risk prediction in type 1 diabetes.
Guo J; Erqou SA; Miller RG; Edmundowicz D; Orchard TJ; Costacou T
Diabetologia; 2019 Feb; 62(2):259-268. PubMed ID: 30426170
[TBL] [Abstract][Full Text] [Related]
28. Coronary calcium in patients with and without diabetes: first manifestation of acute or chronic coronary events is characterized by different calcification patterns.
Shemesh J; Tenenbaum A; Fisman EZ; Koren-Morag N; Grossman E
Cardiovasc Diabetol; 2013 Nov; 12():161. PubMed ID: 24188692
[TBL] [Abstract][Full Text] [Related]
29. Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial.
Myhre PL; Kalstad AA; Tveit SH; Laake K; Schmidt EB; Smith P; Nilsen DWT; Tveit A; Solheim S; Arnesen H; Seljeflot I
J Intern Med; 2022 May; 291(5):637-647. PubMed ID: 34982486
[TBL] [Abstract][Full Text] [Related]
30. Does coronary CT angiography improve risk stratification over coronary calcium scoring in symptomatic patients with suspected coronary artery disease? Results from the prospective multicenter international CONFIRM registry.
Al-Mallah MH; Qureshi W; Lin FY; Achenbach S; Berman DS; Budoff MJ; Callister TQ; Chang HJ; Cademartiri F; Chinnaiyan K; Chow BJ; Cheng VY; Delago A; Gomez M; Hadamitzky M; Hausleiter J; Kaufmann PA; Leipsic J; Maffei E; Raff G; Shaw LJ; Villines TC; Cury RC; Feuchtner G; Plank F; Kim YJ; Dunning AM; Min JK
Eur Heart J Cardiovasc Imaging; 2014 Mar; 15(3):267-74. PubMed ID: 23966421
[TBL] [Abstract][Full Text] [Related]
31. Oral calcium supplements do not affect the progression of aortic valve calcification or coronary artery calcification.
Bhakta M; Bruce C; Messika-Zeitoun D; Bielak L; Sheedy PF; Peyser P; Sarano M
J Am Board Fam Med; 2009; 22(6):610-6. PubMed ID: 19897688
[TBL] [Abstract][Full Text] [Related]
32. Differences in the association of total versus local coronary artery calcium with acute coronary syndrome and culprit lesions in patients with acute chest pain: The coronary calcium paradox.
Puchner SB; Mayrhofer T; Park J; Lu MT; Liu T; Maurovich-Horvat P; Ghemigian K; Bittner DO; Fleg JL; Udelson JE; Truong QA; Hoffmann U; Ferencik M
Atherosclerosis; 2018 Jul; 274():251-257. PubMed ID: 29703635
[TBL] [Abstract][Full Text] [Related]
33. Association between the ratio of serum eicosapentaenoic acid to arachidonic acid and risk of coronary artery disease in young Chinese patients.
Liu X; Sun L; Wen W; Qiu M; Luo J; Li W; Hao S; He M; Wu J; Hu Y; Huang Y
Front Nutr; 2022; 9():1019058. PubMed ID: 36407537
[TBL] [Abstract][Full Text] [Related]
34. Low serum docosahexaenoic acid is associated with progression of coronary atherosclerosis in statin-treated patients with diabetes mellitus: results of the treatment with statin on atheroma regression evaluated by intravascular ultrasound with virtual histology (TRUTH) study.
Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I
Cardiovasc Diabetol; 2014 Jan; 13():13. PubMed ID: 24410834
[TBL] [Abstract][Full Text] [Related]
35. The ratio of eicosapentaenoic acid to docosahexaenoic acid as a modulator for the cardio-metabolic effects of omega-3 supplements: A meta-regression of randomized clinical trials.
AbuMweis S; Abu Omran D; Al-Shami I; Jew S
Complement Ther Med; 2021 Mar; 57():102662. PubMed ID: 33418065
[TBL] [Abstract][Full Text] [Related]
36. The effect of curcumin and high-content eicosapentaenoic acid supplementations in type 2 diabetes mellitus patients: a double-blinded randomized clinical trial.
Asghari KM; Saleh P; Salekzamani Y; Dolatkhah N; Aghamohammadzadeh N; Hashemian M
Nutr Diabetes; 2024 Apr; 14(1):14. PubMed ID: 38589346
[TBL] [Abstract][Full Text] [Related]
37. Effect of Intensive and Standard Pitavastatin Treatment With or Without Eicosapentaenoic Acid on Progression of Coronary Artery Calcification Over 12 Months - Prospective Multicenter Study.
Miyoshi T; Kohno K; Asonuma H; Sakuragi S; Nakahama M; Kawai Y; Uesugi T; Oka T; Munemasa M; Takahashi N; Mukohara N; Habara S; Koyama Y; Nakamura K; Ito H;
Circ J; 2018 Jan; 82(2):532-540. PubMed ID: 28867681
[TBL] [Abstract][Full Text] [Related]
38. Increased risk of coronary artery calcification progression in subjects with high baseline Lp(a) levels: The Kangbuk Samsung Health Study.
Cho JH; Lee DY; Lee ES; Kim J; Park SE; Park CY; Lee WY; Oh KW; Park SW; Rhee EJ
Int J Cardiol; 2016 Nov; 222():233-237. PubMed ID: 27497100
[TBL] [Abstract][Full Text] [Related]
39. Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative.
Manson JE; Allison MA; Carr JJ; Langer RD; Cochrane BB; Hendrix SL; Hsia J; Hunt JR; Lewis CE; Margolis KL; Robinson JG; Rodabough RJ; Thomas AM;
Menopause; 2010 Jul; 17(4):683-91. PubMed ID: 20551849
[TBL] [Abstract][Full Text] [Related]
40. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
